1H,4H,7H-pyrazolo[4,3-d]pyrimidin-7-one, 98%, 100mg

4,5-Dichloro-benzothiazol-2-ylamine, 95.0%, 1g

1-[(2R,3S,4R,5R)-3,4-bis(benzoyloxy)-2-[(benzoyloxy)methyl]-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]triaz-2-yn-2-ium-1-ide, 97%, 250mg

(2-(2,2,2-Trifluoroethoxy)pyridin-3-yl)boronic acid, 98%, 1g

3-(2,4,6-Trifluorophenyl)-1,2-oxazol-5-amine, 95%, 1g

3-Methyl-3-azabicyclo[3.2.1]octan-8-amine dihydrochloride, 95%, 500mg

N-(1-(2,4-Bis(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-5-(furan-2-yl)isoxazole-3-carboxamide, 97%, 10mg

Coperchio, morsetto e anello del recipiente di reazione Coperchio NS 29/32, 19/26, 14/23

4-Bromobenzylamine, 97.0%, 25g

Tappi di chiusura LABOCAP con manico per 15/16 mm, blu 100 pz

(2-imidazo[1,2-a]pyrimidin-2-ylethyl)amine dihydrochloride hydrate, 95.0%, 250mg

tert-Butyl (4-formylpyridin-2-yl)carbamate, 95.0%, 100mg

METHYL 1-(HYDROXYMETHYL)CYCLOBUTANE-1-CARBOXYLATE, 95.0%, 250mg